From July 1, 2023 to September 30, 2023, the company has repurchased 3,139,400 shares, representing 0.85% for ¥4,087.94 million. With this, the company has completed the repurchase of 8,809,300 shares, representing 2.36% for ¥11,124.4 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,632 JPY | +5.43% | +6.74% | +16.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.16% | 3.81B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.